These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17717020)

  • 1. Immune responses to myelin proteins in Guillain-Barré syndrome.
    Makowska A; Pritchard J; Sanvito L; Gregson N; Peakman M; Hayday A; Hughes R
    J Neurol Neurosurg Psychiatry; 2008 Jun; 79(6):664-71. PubMed ID: 17717020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy.
    Sanvito L; Makowska A; Mahdi-Rogers M; Hadden RD; Peakman M; Gregson N; Nemni R; Hughes RA
    J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):333-8. PubMed ID: 19015227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy.
    Inglis HR; Csurhes PA; McCombe PA
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):419-22. PubMed ID: 17158557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell responses to myelin proteins in Guillain-Barré syndrome.
    Khalili-Shirazi A; Hughes RA; Brostoff SW; Linington C; Gregson N
    J Neurol Sci; 1992 Sep; 111(2):200-3. PubMed ID: 1279128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses in the Guillain-Barré syndrome.
    Hartung HP; Kieseier RC
    J Neurol Sci; 1999 Oct; 168(2):75-7. PubMed ID: 10526186
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody responses to P0 and P2 myelin proteins in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.
    Khalili-Shirazi A; Atkinson P; Gregson N; Hughes RA
    J Neuroimmunol; 1993 Jul; 46(1-2):245-51. PubMed ID: 7689591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of serum response to PMP22, connexin 32 and P(0) in inflammatory neuropathies.
    Kwa MS; van Schaik IN; Brand A; Baas F; Vermeulen M
    J Neuroimmunol; 2001 Jun; 116(2):220-5. PubMed ID: 11438177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 and IFN-gamma in Guillain-Barré syndrome. Network Members of the Swedish Epidemiological Study Group.
    Press R; Deretzi G; Zou LP; Zhu J; Fredman P; Lycke J; Link H
    J Neuroimmunol; 2001 Jan; 112(1-2):129-38. PubMed ID: 11108941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barré syndrome.
    Dahle C; Ekerfelt C; Vrethem M; Samuelsson M; Ernerudh J
    J Neurol Sci; 1997 Dec; 153(1):54-60. PubMed ID: 9455979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate Immunity to Campylobacter jejuni in Guillain-Barré Syndrome.
    Huizinga R; van den Berg B; van Rijs W; Tio-Gillen AP; Fokkink WJ; Bakker-Jonges LE; Geleijns K; Samsom JN; van Doorn PA; Laman JD; Jacobs BC
    Ann Neurol; 2015 Sep; 78(3):343-54. PubMed ID: 26017721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-PMP22 antibodies in patients with inflammatory neuropathy.
    Gabriel CM; Gregson NA; Hughes RA
    J Neuroimmunol; 2000 May; 104(2):139-46. PubMed ID: 10713353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TH1 and TH2 response to Campylobacter jejuni antigen in Guillain-Barre syndrome.
    Nyati KK; Prasad KN; Rizwan A; Verma A; Paliwal VK
    Arch Neurol; 2011 Apr; 68(4):445-52. PubMed ID: 21482924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy.
    Allen D; Giannopoulos K; Gray I; Gregson N; Makowska A; Pritchard J; Hughes RA
    J Peripher Nerv Syst; 2005 Jun; 10(2):174-80. PubMed ID: 15958128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of possible cytokine induction in peripheral blood mononuclear cells by heat-stable serotypes of Campylobacter jejuni.
    Chatzipanagiotou S; Michalopoulou M; Marinou I; Boufidou F; Papavasileiou E; Trikka-Graphakos E; Kabouri E; Nicolaou C; Legakis NJ
    Clin Microbiol Infect; 2005 Jan; 11(1):63-5. PubMed ID: 15649306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.
    Enders U; Karch H; Toyka KV; Michels M; Zielasek J; Pette M; Heesemann J; Hartung HP
    Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peripheral nerve myelin antigen-specific T cells in human].
    Ota K; Shimizu Y; Ueda M; Akiyama N; Iwata M
    Rinsho Shinkeigaku; 1996 Jul; 36(7):898-901. PubMed ID: 8952362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barré syndrome.
    Schmidt-Ott R; Schmidt H; Feldmann S; Brass F; Krone B; Gross U
    Clin Vaccine Immunol; 2006 Jul; 13(7):779-83. PubMed ID: 16829615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated number of cells secreting transforming growth factor beta in Guillain-Barré syndrome.
    Dahle C; Kvarnstrom M; Ekerfelt C; Samuelsson M; Ernerudh J
    APMIS; 2003 Dec; 111(12):1095-104. PubMed ID: 14678018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.